Quant Healthcare Fund Direct-Growth
Quant
Detailed equity portfolio holdings for Quant Healthcare Fund Direct-Growth, showing each stock's allocation percentage, monthly changes in weight, sector breakdown, and whether the fund has been increasing or decreasing its position.
11 holdings· 70.29% in equity
Equity holdings as last captured from the fund's monthly portfolio disclosure. Funds publish with a lag, so this can trail the latest disclosure by a month. Changes compare with the previous different capture.
| Stock | Allocation % | Change (pp) | Sector | Trend |
|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd GLAXO | 10.58% | +0.65 pp | Healthcare | Increased |
| Zydus Lifesciences Ltd ZYDUSLIFE | 9.30% | +9.30 pp | Healthcare | New |
| Pfizer Ltd PFIZER | 8.83% | +3.00 pp | Healthcare | Increased |
| Alivus Life Sciences Ltd ALIVUS | 8.08% | +0.89 pp | Healthcare | Increased |
| Concord Biotech Ltd CONCORDBIO | 7.03% | -2.62 pp | Healthcare | Decreased |
| SMS Pharmaceuticals Ltd SMSPHARMA | 6.71% | -0.57 pp | Healthcare | Decreased |
| Ipca Laboratories Ltd IPCALAB | 6.22% | +0.28 pp | Healthcare | Increased |
| Zydus Wellness Ltd ZYDUSWELL | 5.64% | -3.69 pp | Food Products | Decreased |
| Aurobindo Pharma Ltd AUROPHARMA | 5.14% | 0.00 pp | Healthcare | Unchanged |
| Strides Pharma Science Ltd STAR | 2.45% | -0.19 pp | Healthcare | Decreased |
| Sumitomo Chemical India Ltd SUMICHEM | 0.31% | -0.02 pp | Chemicals | Decreased |